News
Data from a limited number of trials hint that GLP-1 use might improve erectile dysfunction and testosterone levels for men, but more research is needed to provide a clearer picture, researchers ...
But a new study suggests something else might be at play.
Aging men aren't just battling time—they're up against rising blood sugar. New research reveals that subtle increases in ...
5d
Mid-Day on MSNFinland Digital Care Moves FirstThe Two Speeds of European Healthcare Finland is demonstrating a different approach to modern healthcare—one that prioritizes ...
USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...
Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.
Dubbed the “King Kong” of weight loss jabs, Mounjaro, the brand name for tirzepatide, is a weekly injection licensed to treat type 2 diabetes on the NHS.
Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.
It contains tirzepatide, which is the active ingredient in the brand-name drug Mounjaro. If you cannot take Mounjaro for medical reasons, you may need compounded tirzepatide.
Hosted on MSN2mon
New Daily GLP-1 Weight Loss Pill Gets One Step Closer - MSNHe was previously a reporter for DailyRx.com where he covered stories related to cardiology, diabetes, lung cancer, prostate cancer, erectile dysfunction, menopause, and allergies.
Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results